The intracellular HCV-NS3 (A) as well as Hsc70 protein (B) decreased dose-dependently in the Huh7.5 cells untreated or treated with 7c (31.25, 62.5, 125 and 250 µg/mL, respectively) for 72 h. by Na-Na Du (389557)

“…<p>The intracellular HCV-NS3 (A) as well as Hsc70 protein (B) decreased dose-dependently in the Huh7.5 cells untreated or treated with 7c (31.25, 62.5, 125 and 250 µg/mL, respectively) for 72 h.…”

The transcript and protein abundances of several VAC-residing proteases were decreased in Δ<i>crt</i>. by L. Brock Thornton (6808385)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

Stored red blood cells were incubated with DMSO or normal saline (NS), then incubated in bypass plasma. by Lu Han (151620)

Ppk1 levels are not affected by decreasing dendrite arbor size but are reduced when dendrite length increases. by Josephine W. Mitchell (17364781)

Pep4 overexpression decreased APCs in Vps21- and ESCRT-mutant cells after nitrogen starvation. by Zulin Wu (4451572)

“…Either Pep4 or Snf7 in <i>snf7Δ</i> cells facilitated GFP-Atg8 degradation and prApe1 maturation (bottom), but only Snf7 (not Pep4) promoted phagophore closure in <i>snf7Δ</i> cells. The red arrows point to these key results. <b>F.</b> Quantification of the immunoblot results shown in panel E was performed as described in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1010431#pgen.1010431.s008" target="_blank">S8F Fig</a>. …”

Response of small airway tissues infected with EV-D94 and decreasing doses of EV-D68. by Ines Cordeiro Filipe (5849144)

“…<p>Tissues were infected with 1E7 RNA copies of EV-D94 (equivalent to 2,46E4 TCID50) and 1E7 RNA copies of EV-D68 (3,3E5 TCID50) as well as decreasing doses of the latter. …”

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

Increases in 1,5-anhydrosorbitol and decreases in ascorbic acid following RYGB. by David M. Mutch (37665)

“…B) For ascorbic acid, the ANOVA model did not detect group-specific changes over time (no group:time interaction), but indicated significant decreases from T0 to T6 in both groups. Overall, 1,5-anhydrosorbitol and ascorbic acid were significantly different at each time point between OB and OB/D subgroups (p<0.01, see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0007905#pone-0007905-t002" target="_blank"><b>TABLE 2</b></a>).…”

DPI, NAC and resveratrol decrease lipolysis. by Sarah A. Krawczyk (172699)

ETHE1-p.Arg163Gln and p.Arg163Trp are folded but have decreased stability. by Bárbara J. Henriques (627180)

Genetic correlations in viral load between single and coinfections of CrPV and DCV. by Ryan M. Imrie (15810854)

Subjects:

Interspecific correlations in viral load between single and coinfections of CrPV and DCV. by Ryan M. Imrie (15810854)

Subjects:

Naringenin decreases total cell viability. by Lauren A. Eanes (20995499)

Chimera and wild-type virus replication at early time points. by Anja vom Hemdt (19787189)

28 days of testosterone depletion decreases fiber CSA only in the TA muscle and only at 1.5-month-old mice. by Arik Davidyan (10450896)

Pre-treatment of IOZCAS-Spex-II cells with CPT and HCPT decreased Topo1 specific activity in a time-dependent manner. by Lan Zhang (90951)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

Pharmacological inhibition of EGFR decreases early fungal burden and reduces the inflammatory response. by Marc Swidergall (185453)